Table 2 Inclusion and exclusion criteria of systematic reviews for assessing safety outcomes in clinical trials of cardiovascular diseases
Inclusion criteria | Exclusion criteria |
|---|---|
Adult patients with angina pectoris, myocardial infarction, heart failure, essential hypertension, arrhythmia, atrial fibrillation, ventricular premature beats, atrial premature beats, or tachycardia, bradycardia | No adverse events/reactions can be extracted |
Interventions include Chinese herbal medicines and Western medicines included in the National Medical Insurance Catalog or the National Essential Medicines Catalog for cardiovascular diseases | No causality assessment of adverse events/reactions |
Adverse events/reactions should be reported | Full-text cannot be obtained |
Randomized controlled trials, observational studies, case reports, and case series | Interventions are operations or other types of non-pharmacological therapies |
Literatures published in Chinese or English | Â |